dc.contributoren-US
dc.creatorFernández López, Rocío Gloria
dc.creatorArellano Flores, Águeda
dc.creatorVelázquez Serrano, Sayra Nayelli
dc.date2013-04-17
dc.date.accessioned2018-03-16T15:58:46Z
dc.date.available2018-03-16T15:58:46Z
dc.identifierhttp://ojs.unam.mx/index.php/rom/article/view/37121
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1204090
dc.descriptionThe aim of the present paper was to present the associationbetween mandibular osteonecrosis and use of bisphosphonatesfor therapeutic purposes. Bisphosphonates are drugs used forthe treatment of primary and secondary bone disorders. They aremainly used for local and general osteoporosis treatment, metabolicbone diseases, soft tissue calcifi cation as well as hypercalcemiaoccurrence, among others. They can also act as antineoplasticagents through the inhibition of activation of cancer-linked proteins.In recent years, bisphosphonates have been used to prevent postmenopausaeosteoporosis, since they enhance mineral densityincrease in bone and therefore contribute to a decrease in fractures.The clinical case here presented is that of a 61 year old femalepatient with previous history of breast cancer and ongoing 3 yearbisphosphonate intake. The patient presented asymptomatic,spontaneous bone exposition. Surgical and medical handlings of thecase are presented, as well as its evolution.en-US
dc.formatapplication/pdf
dc.languagespa
dc.publisherFacultad de Odontologíaes-ES
dc.relationhttp://ojs.unam.mx/index.php/rom/article/view/37121/33708
dc.sourceRevista Odontológica Mexicana; Vol 17, No 1-INGes-ES
dc.source1870-199X
dc.subjecten-US
dc.subjectBisphospohonates, jaw osteonecrosisen-US
dc.titleBisphosphonate-associated jaw osteonecrosis. Clinical case presentationen-US
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución